Here’s Why Traders are Talking about These Five Stocks

Nucor Reports Earnings

Nucor Corporation (NYSE:NUE)’s stock has lost over 2% today after the company reported second quarter earnings of $0.73 per share on sales of $4.25 billion, beating the profit estimate by $0.03 per share but missing the revenue consensus by $250 million. Average sales price per ton increased by 9% sequentially and fell by 9% year-over-year. Total tons shipped gained 5% sequentially and jumped by 7% year-over-year. Overall operating rate at the company’s steel mills rose to 83% from 73% as demand increased markedly. Among the investors we track, 29 funds owned $524.19 million worth of Nucor Corporation (NYSE:NUE)’s stock, which accounted for 3.50% of the float on March 31, versus 20 funds and $301.41 million, respectively, a quarter earlier.

Domino’s Surges Around 6% on Results

Domino’s Pizza, Inc. (NYSE:DPZ) earned $0.98 per share on sales of $547.34 million in the second quarter, beating the average analyst estimates by $0.04 per share and $13.9 million, respectively. Overall revenue appreciated by 12% year-over-year, aided by a 9.7% increase in domestic same-store sales and a 7.1% rise in international same-store sales. Total store count went up by more than 1,000 year-over-year to 12,936. Meanwhile, the company’s operating margin inched up 10 basis points to 19%. Jim Simons’ Renaissance Technologies was one of the 32 funds tracked by Insider Monkey that held shares of Domino’s Pizza, Inc. (NYSE:DPZ) at the end of March.

Quest Diagnostics Rises on Earnings

Quest Diagnostics Inc (NYSE:DGX) is 1.5% in the green after the company reported EPS of $1.34 on revenue of $1.91 billion for the second quarter, beating the bottom-line estimate by $0.02 per share and meeting the top-line expectations. Management sees full year 2016 revenue between $7.47 billion and $7.54 billion and full year 2016 adjusted diluted EPS, excluding amortization expenses, between $5.02 and $5.17. Shares of the company are up by over 19% year-to-date. Cliff Asness’ AQR Capital Management raised its stake in Quest Diagnostics Inc (NYSE:DGX) by 5% to over 1.6 million shares during the first quarter.

Disclosure: none